COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 427: Articles 4261-4270  | Next

Socio-demographic determinants of COVID-19 vaccine uptake in Ontario: Exploring differences across the Health Region model
Mundo Ortiz, A. I., Nasri, B.
10.1101/2023.08.04.23293662 — Posted: 2023-08-08
Genetic Variant rs1205 is Associated with COVID-19 Outcomes: The Strong Heart Study and Strong Heart Family Study.
Best, L. G., Erdei, E., Haack, K., Kent, J. W., Malloy, K., Newman, D. E., O'Leary, M., O'Leary, R., Sun, Q., Navas-Acien, A., Franceschini, N., Cole, S. A.
10.1101/2023.08.04.23293551 — Posted: 2023-08-08
Infant and Neonatal Mortality During the Covid-19 Pandemic: An Interrupted Time Series Analysis From Five Low- and Middle-Income Countries
Wagner, Z., Heft-Neal, S., Wang, Z., Jing, R., Bendavid, E.
10.1101/2023.08.03.23293619 — Posted: 2023-08-08
NVX-CoV2373 ancestral and NVX-CoV2540 BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters
Bricker, T. L., Joshi, A., Soudani, N., Scheaffer, S., Patel, N., Xabier, M. G., Smith, G., Diamond, M., Boon, A. C.
10.1101/2023.08.07.552330 — Posted: 2023-08-08
Within-host evolution of SARS-CoV-2: how often are mutations transmitted?
Korosec, C. S., Wahl, L. M., Heffernan, J. M.
10.1101/2023.08.08.552503 — Posted: 2023-08-08
Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against Omicron subvariants including EG.5
Kaku, Y., Kosugi, Y., Uriu, K., Ito, J., Kuramochi, J., Sadamasu, K., Yoshimura, K., Asakura, H., Nagashima, M., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Sato, K.
10.1101/2023.08.08.552415 — Posted: 2023-08-08
Determinants of COVID-19 booster uptake in the Netherlands, Autumn 2022: how well were those at risk for severe disease reached?
van Roekel, C., Labuschagne, L., Pijpers, J., van Roon, A., Smagge, B., Ferreira, J. A., Hahne, S., de Melker, H.
10.1101/2023.08.04.23293632 — Posted: 2023-08-07
Determinants of COVID-19 vaccine uptake in the Netherlands: a nationwide registry-based study
Pijpers, J., van Roon, A., van Roekel, C., Labuschagne, L., Smagge, B., Ferreira, J. A., de Melker, H., Hahne, S.
10.1101/2023.08.03.23293593 — Posted: 2023-08-07
Wastewater Based Epidemiology as a surveillance tool during the current COVID-19 pandemic on a college campus (East Carolina University) and its accuracy in predicting SARS-CoV-2 outbreaks in dormitories
White, A., Iverson, G., Wright, L., Fallon, J. T., Briley, K., Yin, C., Huang, W., Humphrey, C.
10.1101/2023.08.04.23293359 — Posted: 2023-08-07
Recombinant SARS-CoV-2 lacking initiating and internal methionine codons within ORF10 is attenuated in vivo
Gu, S., Bentley, E. G., Milligan, R. I., Almuqrin, A. M., Sharma, P., Kirby, A., Mega, D. F., Kipar, A., Erdmann, M., Bazire, J., Heesom, K. J., Lewis, P. A., Donovan-Banfield, I., Reston, C., Webb, I., de Neck, S., Dong, X., Hiscox, J. A., Davidson, A. D., Stewart, J. P., Matthews, D. A.
10.1101/2023.08.04.551973 — Posted: 2023-08-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).